Neurotechnology—ranging from brain-computer interfaces to neural stimulation—offers India major gains in health, innovation, and economic growth by improving treatment for neurological disorders, enabling assistive devices, and creating new tech industries. Globally, countries like the U.S., China, and Chile are advancing neurotech while shaping ethical norms and neurorights. However, its promise depends on strong regulation that safeguards mental privacy, autonomy, equity, and long-term safety. If India builds research capacity, industry linkages, and ethical oversight,
Click to View MoreScientists have discovered a special type of brain immune cell called microglia that can protect against Alzheimer’s disease by reducing inflammation and slowing the buildup of harmful proteins like amyloid plaques and tau. These cells work through molecules PU.1 and CD28, offering a potential new direction for treatment. Alzheimer’s, a progressive brain disorder causing memory and cognitive decline, is a growing public health challenge globally and in India. Governments are responding with awareness campaigns, healthcare policies, and research initiatives, but challenges like high costs, limited access, and early diagnosis remain. The discovery highlights the promise of combining scientific research, healthcare, and policy to combat Alzheimer’s disease.
Click to View MoreDeep Brain Stimulation (DBS) is a surgical procedure that uses electrodes to target specific areas of the brain, to help patients with neurological disorders like Parkinson's. DBS can reduce symptoms like tremors and involuntary shaking. However, its high cost and limited accessibility make it largely inaccessible to many people.
Click to View More
© 2025 iasgyan. All right reserved